Partnership


At Brise pharma, collaboration is one of our core values. We strive to establish mutually beneficial, long-term external partnerships to accelerate innovation and maximize pipeline value by fully leveraging expertise of both parties. We employ a flexible business development strategy to shape and expand our business in the global pain management market.

Out-Licensing

We are actively seeking partners to out-license our assets. By integrating the expertise of both parties, we are better positioned to offer solutions for patients and finally maximize the benefits of a collaboration.

Co-development / R&D Collaborations

Co-development and early-stage R&D collaborations for novel targets and modalities help broaden asset potential.

License-in / M&A

In addition to internal research, we are also interested in enhancing our pipeline through in-licensing collaboration or M&A.

Let’s keep in touch

Address


Brise Pharmaceuticals Co. Ltd.
2555 Xiupu Road, Building E3, 8F
Pudong New District, Shanghai, China

Email: BD@brisepharma.com